This AI Chip Design Stock Is 24% Below Its High While Revenue Grew 42%. Wall Street Is Focused on the Wrong Number

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • SNPS trades 24% below its 52-week high while 42% revenue growth and an emerging agentic AI catalyst go largely unrecognized by Wall Street.

  • Ansys loaded $10B in debt onto SNPS and crushed GAAP net income 95%, but a forward P/E of 35 versus trailing 114 signals expected earnings normalization.

  • A September 30 Investor Day, an $11.4B backlog, and 17 of 25 analysts rating SNPS a Buy make the risk/reward attractive up to $535.

  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Synopsys didn't make the cut. Grab the names FREE today.

This AI Chip Design Stock Is 24% Below Its High While Revenue Grew 42%. Wall Street Is Focused on the Wrong Number

© Pure Storage

At $494.48, Synopsys (NASDAQ:SNPS | SNPS Price Prediction) looks constructive at current levels, with the chip design software leader trading well below its $651.73 52-week high as Wall Street fixates on accounting noise from the $35 billion Ansys acquisition rather than the agentic AI catalyst building underneath.

Synopsys sits at the center of every advanced chip designed on the planet. Its electronic design automation (EDA) software, paired with the Ansys acquisition that closed July 17, 2025, pushed the company from silicon design into full silicon-to-systems engineering. After a brutal 35.84% single-day drop on the Q3 FY2025 miss, the stock has stabilized as the integration story has shifted from risk to reward.

The Agentic AI Inflection Wall Street Is Underwriting at a Discount

The bull case starts with raw demand. Q2 FY2026 revenue hit $2.275 billion, up 41.98% year over year, with non-GAAP EPS of $3.35 beating the $3.16 consensus by 5.96%. Management raised full-year guidance to a $9.665 billion revenue midpoint and $14.76 non-GAAP EPS midpoint, with free cash flow targeted at roughly $2.0 billion.

Design Automation, which makes up about 80% of revenue, expanded its adjusted operating margin to 43.3% from 40.9%. The hidden catalyst is the commercial ramp of Multiphysics Fusion software in late 2026, with dozens of major customers already testing specialized AI agents that compress chip design timelines by up to 3x. The Investor Day on September 30, 2026 is the likely catalyst for revealing long-term targets that anchor this story.

The Debt, Dilution, and GAAP Compression Bear Case

Bears have a real argument. The Ansys deal saddled Synopsys with $10 billion in long-term debt, and quarterly GAAP results are buried under $403.6 million of intangibles amortization. Q2 GAAP net income collapsed 95.05% year over year to $17.1 million. The Design IP segment is being restructured around a planned divestiture, restructuring charges hit $234.2 million in H1 FY2026, and shareholder lawsuits over prior Design IP disclosures remain unresolved. A trailing P/E of 114 is not cheap on reported earnings.

The Case for Sitting on Hands

The hold view is that the stock has gone nowhere fast. Shares are up 5.27% year to date and 4.5% over one year, well behind the S&P 500’s roughly 10.8% YTD gain. The 50-day moving average of $463.89 and 200-day of $467.86 signal consolidation, not a breakout. Patient investors could wait for the September Investor Day to remove ambiguity before committing fresh capital.

What the Numbers Say About the Setup

Synopsys currently trades at $494.48 against a Wall Street consensus target of $560.38, implying roughly 13% upside. Analyst targets are guidance only. Of 25 analysts, 17 rate it Buy or Strong Buy, 7 Hold, and 1 Strong Sell. The forward P/E of 35 versus trailing P/E of 114 reflects expected earnings normalization as Ansys amortization rolls through. Institutional ownership sits at 90.89%.

Why $495 Looks Like a Constructive Setup Before the September Catalyst

At $494.48, the setup for Synopsys looks constructive. Here is why.

The setup compresses three catalysts into the next four months. Q3 FY2026 guidance calls for revenue of $2.41 to $2.46 billion and non-GAAP EPS of $3.63 to $3.69, which would extend the beat streak. The September 30, 2026 Investor Day should quantify Ansys synergy targets and frame the agentic AI roadmap.

The risk/reward profile looks attractive up to $535. Downside is cushioned by the $11.4 billion backlog, $2 billion FCF run rate, and $3.46 billion in debt repayment during H1 FY2026. The thesis breaks if Design IP weakness widens or another Q3 FY2025-style miss surfaces.

Owning a dominant duopoly EDA franchise before its agentic AI moment, while GAAP optics still obscure the underlying engine, is the setup investors are weighing.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

COO Vol: 4,443,693
CMG Vol: 18,119,445
ALL Vol: 648,780
WELL Vol: 961,350
PODD Vol: 869,099

Top Losing Stocks

ENPH Vol: 5,020,891
FSLR Vol: 2,102,934
SMCI Vol: 29,174,678
QCOM Vol: 9,651,353
MU Vol: 39,382,869